Forte Biosciences, Inc.
FBRX
$12.88
-$0.785-5.75%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
6/27/2025
-
Ticker Report
6/26/2025
-
MarketBeat
6/25/2025
-
TipRanks Financial Blog
6/25/2025
-
GuruFocus
6/25/2025
-
SeekingAlpha.com: All News
6/25/2025
-
Seeking Alpha - Healthcare
6/25/2025
-
GuruFocus
6/25/2025
-
GuruFocus
6/25/2025
-
Business Wire
6/24/2025
-
GuruFocus
6/24/2025
-
GuruFocus
6/24/2025
-
GuruFocus
6/24/2025
-
Seeking Alpha - Healthcare
6/24/2025
-
TipRanks Financial Blog
6/24/2025
-
The Fly
6/24/2025
-
Business Wire
6/24/2025
-
GuruFocus
6/24/2025
-
MarketBeat
6/24/2025
-
ETF Channel
6/23/2025
-
GuruFocus
6/23/2025
-
TipRanks Financial Blog
6/23/2025
-
The Fly
6/23/2025
-
GuruFocus
6/23/2025
-
Business Wire
6/17/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 15, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
310 618 6994
Address
3060 Pegasus Park Drive
Dallas, TX 75247
Dallas, TX 75247
Country
Year Founded
--
Business Description
Sector
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal...
more